In this episode, Dr. Jennifer Green discusses key continuous glucose monitoring (CGM) updates to the 2025 American Diabetes Association (ADA) Standards of Care in Diabetes.

This material is made possible thanks to an independent educational grant from Abbott. Intended for healthcare professionals only.

This episode is part of the Independent Medical Education program entitled, 'T2D & CKD: Putting evidence into practice'. This independent medical educational program will support the multidisciplinary team (MDT) to proactively identify and manage patients with CKD and T2D whilst incorporating the latest clinical guidelines. In a series of vodcasts, our expert faculty will explain best practices for the identification, classification and management of CKD in T2D, drawing on recent advances in therapies and insights from a patient with these comorbidities.

To learn more about the full program, visit https://ckd-t2d.ime.springerhealthcare.com/

The information and data provided in this program was updated and correct at the time of the program development, but may be subject to change. This educational activity is intended for an international audience of non-US and non-UK HCPs.

This program is supported by an educational grant from Novo Nordisk A/S.

As part of our independent medical education program, featuring conference coverage in the rapidly progressing field of Alzheimer's Disease, we bring you the latest news and updates from the major neurology congresses throughout 2024.

Direct from CTAD 2024 Claire Paquet presents this episode on the implications of real-world and recommendation data on anti-amyloid antibody therapies for Alzheimer's disease.

This activity is supported by an educational grant from Lilly.---

As part of our independent medical education program, featuring conference coverage in the rapidly progressing field of Alzheimer's Disease, we bring you the latest news and updates from the major neurology congresses throughout 2024.

Direct from CTAD 2024 this episode features Juan Fortea who discusses future opportunities for anti-amyloid antibody treatment in view of real-world clinical trial data.

This activity is supported by an educational grant from Lilly.---

This program is made possible thanks to an independent educational grant from Abbott

As part of our independent medical education program, featuring conference coverage in the rapidly progressing field of Alzheimer's Disease, we bring you the latest news and updates from the major neurology congresses throughout 2024. In this episode direct from AAIC24 Dr Petrice Cogswell summarizes research looking at temporal modelling of blood-based biomarkers and when to use them to predict brain amyloid deposition. This activity is supported by an educational grant from Lilly.

As part of our independent medical education program, featuring conference coverage in the rapidly progressing field of Alzheimer's Disease, we bring you the latest news and updates from the major neurology congresses throughout 2024.

In this episode, from onsite at AAIC24, Professor Michelle Mielke discusses the current status for blood-based biomarker use in primary care, in light of research presented at the conference.

This activity is supported by an educational grant from Lilly.

As part of our independent medical education program, featuring conference coverage in the rapidly progressing field of Alzheimer's Disease, we bring you the latest news and updates from the major neurology congresses throughout 2024.

In this episode, from onsite at AAIC24, Dr Rik Ossenkoppele discusses the latest research presented on blood-based biomarkers, including their accuracy for diagnosing Alzheimer’s disease and when best to use them

This activity is supported by an educational grant from Lilly.

In this episode, Professor Niloaus Marx exploring advances in therapies available for CKD in T2D and the clinical evidence and guidelines supporting their use.

This episode is part of the Independent Medical Education program entitled, 'T2D & CKD: Putting evidence into practice'. This independent medical educational program will support the multidisciplinary team (MDT) to proactively identify and manage patients with CKD and T2D whilst incorporating the latest clinical guidelines. In a series of vodcasts, our expert faculty will explain best practices for the identification, classification and management of CKD in T2D, drawing on recent advances in therapies and insights from a patient with these comorbidities.

To learn more about the full program, visit https://ckd-t2d.ime.springerhealthcare.com/

The information and data provided in this program was updated and correct at the time of the program development, but may be subject to change. This educational activity is intended for an international audience of non-US and non-UK HCPs.

This program is supported by an educational grant from Novo Nordisk A/S.

For this episide, Professor David Cherney discusses the evidence-based guidelines for management of CKD in T2D and how these can be integrated into clinical practice.

This episode is part of the Independent Medical Education program entitled, 'T2D & CKD: Putting evidence into practice'. This independent medical educational program will support the multidisciplinary team (MDT) to proactively identify and manage patients with CKD and T2D whilst incorporating the latest clinical guidelines. In a series of vodcasts, our expert faculty will explain best practices for the identification, classification and management of CKD in T2D, drawing on recent advances in therapies and insights from a patient with these comorbidities.

To learn more about the full program, visit https://ckd-t2d.ime.springerhealthcare.com/

The information and data provided in this program was updated and correct at the time of the program development, but may be subject to change. This educational activity is intended for an international audience of non-US and non-UK HCPs.

This program is supported by an educational grant from Novo Nordisk A/S.